Professional Documents
Culture Documents
4-[5-(4-metilfenil)-3-(trifluorometil)
pirazol-1-il]benzeno sulfonamida
ANÁLISIS ORGANOLÉPTICO
Atributos Genérico
Olor Inodoro
Sabor Insípido
Estado Solido
Aspecto Pulverizado
Color Blanco
Prueba de solubilidad
Solventes: Solubilidad
Agua destilada Ligeramente soluble
Acetona Insoluble
Benceno Insoluble
ESTRUCTURA MOLECULAR
C17 H14 F3 N3 O2 S
MASA MOLECULAR
38.38
MATERIALES Y REACTIVOS
Gradilla
Tubo de ensayo
Pipeta
Piseta
Balanza analítica
Vernier
INSUMOS
Alcohol
celecoxib
Agua destilada
Acetona
CONCLUSIÓN
En el análisis cualitativo se observó que el celecoxib en la prueba de solubilidad
con alcohol y H2O destilada es ligeramente soluble y con acetona insoluble.
REFERENCIAS BIBLIOGRAFICAS
Sheehan KM, Sheahan K, O'Donoghue DP, et al. The relationship between
cylooxgenase-2 Expression and colorectal cancer. JAMA 1999;282:1254-7.
Rugger AW, Richardson ET, Drupka DT, et al. Comparison of celecoxib,
hydrocodone/acetaminophen, and placebo for relief of post-surgical pain
(abstract/poster 880). Presented at the 1999 Annual Meeting of the American Pain
Society. Retrieved from the World Wide Web November 11, 1999.
www.ampainsoc.org/abstract99/data/44/index.html.
Dougados M, Behier JM, Jolchine I, et al. Celecoxib, a COX-2 selective inhibitor in
ankylosing spondylitis (AS): a 6-week efficacy study. Presented at the 2000
Meeting of the American Rheumatology Society. Retrieved October 31, 2000.
Available on the World Wide Web at www.rheumatology.org.
Steinbach G, Lynch PM, Phillips RKS, et al. The effect of celecoxib, a
cyclooxygenase-2 inibitor, in familial adenomatous polyposis. N Eng J Med
2000;342:1946—52.
Keller JJ, Giardiello FM.Chemoprevention strategies using NSAIDs and COX-2
inhibitors. Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S140-9.
Lugardon S, Lapeyre-Mestre M, Montastruc JL. Upper gastrointestinal adverse drug
reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-
case study from the French Pharmacovigilance Database. Eur J Clin Pharmacol.
2004 Oct 23